Brief: Cassava Sciences Q4 Basic EPS USD -0.5

Filana Therapeutics

28/02/2024 14:14

Feb 28 (Reuters) - Cassava Sciences Q4 operating income USD -22.789 million.
* Q4 net income USD -20.919 million
* Q4 operating expenses USD 22.789 million